Dermatofibroma surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]

Overview

Surgery is the first-line treatment option for patients with dermatofibroma. Surgery is usually used for patients with either cosmetic reasons, symptomatic lesions, uncertain diagnosis and aggressive subtypes. Complete excision which is involved subcutaneous fat incorporated with 1-3 mm margin based on the location of lesion is recommended. Cryosurgery or superficial shaving as a purpose of cosmetic or controlling symptoms are accompanied by increasing risk of recurrence.

Indications

Surgery is the first-line treatment option for patients with dermatofibroma.Surgery is usually used for patients with either:^[1]
- Cosmetic reasons
- Symptomatic lesions (like bleeding)
- Uncertain diagnosis
- Aggressive subtypes ( like aneurysmal dermatofibroma)

Surgery

Complete excision which is involved subcutaneous fat incorporated with 1-3 mm margin based on the location of lesion is recommended. ^[1]^[2]^[3]
Cryosurgery or superficial shaving as a purpose of cosmetic or controlling symptoms are accompanied by increasing risk of recurrence.^[4]

References

↑ ^1.0 ^1.1 Kim, Hee Joo; Kim, Il-Hwan (2015). “A 3-mm Margin Completely Removes Dermatofibromas”. Dermatologic Surgery. 41 (2): 283–286. doi:10.1097/DSS.0000000000000235. ISSN 1076-0512.
↑ Estela, J.R.; Rico, M.T.; Pérez, A.; Unamuno, B.; Garcías, J.; Cubells, L.; Alegre, V. (2014). “Dermatofibromas faciales: estudio clínico-patológico de 20 casos”. Actas Dermo-Sifiliográficas. 105 (2): 172–177. doi:10.1016/j.ad.2013.10.002. ISSN 0001-7310.
↑ T. Mentzel, H. Kutzner, A. Rutten & H. Hugel (2001). “Benign fibrous histiocytoma (dermatofibroma) of the face: clinicopathologic and immunohistochemical study of 34 cases associated with an aggressive clinical course”. The American Journal of dermatopathology. 23 (5): 419–426. PMID 11801774.
↑ W. F. Spiller & R. F. Spiller (1975). “Cryosurgery in dermatologic office practice: special reference to dermatofibroma and mucous cyst of the lip”. Southern medical journal. 68 (2): 157–160. PMID 1118748.

Template:WH Template:WS

[KimKim2015-1] 1.0 ^1.1 Kim, Hee Joo; Kim, Il-Hwan (2015). “A 3-mm Margin Completely Removes Dermatofibromas”. Dermatologic Surgery. 41 (2): 283–286. doi:10.1097/DSS.0000000000000235. ISSN 1076-0512.

[EstelaRico2014-2] Estela, J.R.; Rico, M.T.; Pérez, A.; Unamuno, B.; Garcías, J.; Cubells, L.; Alegre, V. (2014). “Dermatofibromas faciales: estudio clínico-patológico de 20 casos”. Actas Dermo-Sifiliográficas. 105 (2): 172–177. doi:10.1016/j.ad.2013.10.002. ISSN 0001-7310.

[3] T. Mentzel, H. Kutzner, A. Rutten & H. Hugel (2001). “Benign fibrous histiocytoma (dermatofibroma) of the face: clinicopathologic and immunohistochemical study of 34 cases associated with an aggressive clinical course”. The American Journal of dermatopathology. 23 (5): 419–426. PMID 11801774.

[4] W. F. Spiller & R. F. Spiller (1975). “Cryosurgery in dermatologic office practice: special reference to dermatofibroma and mucous cyst of the lip”. Southern medical journal. 68 (2): 157–160. PMID 1118748.

[1]

[2]

[3]

[4]

Dermatofibroma surgery

Overview

Indications

Surgery

References

Looking for the patient version?